Results 281 to 290 of about 3,749,228 (399)
Navigating the New Therapeutic Landscape: Innovative Strategies for Overcoming Resistance and Degeneration. [PDF]
Ko HJ, Lee CH.
europepmc +1 more source
Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen +11 more
wiley +1 more source
Humanized Mouse Models as a Cellular Platform for Investigating Immune-Hormonal Crosstalk and Therapeutic Strategies in Menopause. [PDF]
Chandimali N +6 more
europepmc +1 more source
Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer [PDF]
Daniel Chen +17 more
openalex +1 more source
ABSTRACT Objective Peripheral neuropathies contribute to patient disability but may be diagnosed late or missed altogether due to late referral, limitation of current diagnostic methods and lack of specialized testing facilities. To address this clinical gap, we developed NeuropathAI, an interpretable deep learning–based multiclass classification ...
Chaima Ben Rabah +7 more
wiley +1 more source
Editorial: Unraveling circRNAs and miRNAs: key regulators in immune-related diseases. [PDF]
Hakim MS +3 more
europepmc +1 more source
ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein +7 more
wiley +1 more source
Nanomedicine for Cancer and Autoimmune Immunotherapy. [PDF]
Ramavat A +4 more
europepmc +1 more source

